These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38064666)

  • 21. Using Rasch Analysis to Validate the Michigan Hand Outcomes Questionnaire from the Wrist and Radius Injury Surgical Trial.
    Jayaram M; Wang B S C; Shauver MJ; Wang L; Chung KC
    Plast Reconstr Surg; 2021 Oct; 148(4):558e-567e. PubMed ID: 34550939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Living with Chronic Illness Scale: International validation through the classic test theory and Rasch analysis among Spanish-speaking populations with long-term conditions.
    Rodriguez-Blazquez C; Forjaz MJ; Ayala A; Portillo MC; Ambrosio L;
    Health Expect; 2021 Dec; 24(6):2065-2077. PubMed ID: 34492734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rasch validation of the Danish version of the shoulder pain and disability index (SPADI) in patients with rotator cuff-related disorders.
    Christensen KB; Thorborg K; Hölmich P; Clausen MB
    Qual Life Res; 2019 Mar; 28(3):795-800. PubMed ID: 30456715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving the measurement of oral health-related quality of life: Rasch model of the oral health impact profile-14.
    Omara M; Salzberger T; Boecker M; Bekes K; Steiner G; Nell-Duxneuner V; Ritschl V; Mosor E; Kloppenburg M; Sautner J; Steinecker-Frohnwieser B; Stamm T
    J Dent; 2021 Nov; 114():103819. PubMed ID: 34560224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measure of activity performance of the hand (MAP-Hand) questionnaire: linguistic validation, cultural adaptation and psychometric testing in people with rheumatoid arthritis in the UK.
    Prior Y; Tennant A; Tyson S; Kjeken I; Hammond A
    BMC Musculoskelet Disord; 2018 Jul; 19(1):275. PubMed ID: 30064399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of the symptom burden questionnaire for long covid (SBQ-LC): Rasch analysis.
    Hughes SE; Haroon S; Subramanian A; McMullan C; Aiyegbusi OL; Turner GM; Jackson L; Davies EH; Frost C; McNamara G; Price G; Matthews K; Camaradou J; Ormerod J; Walker A; Calvert MJ
    BMJ; 2022 Apr; 377():e070230. PubMed ID: 35477524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measurement properties of the Swedish clinical outcomes in routine evaluation outcome measures (CORE-OM): Rasch analysis and short version for depressed and anxious out-patients in a multicultural area.
    Danielsson L; Elfström ML; Galan Henche J; Melin J
    Health Qual Life Outcomes; 2022 Feb; 20(1):30. PubMed ID: 35183201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation properties of the French version of the OUT-PATSAT35 satisfaction with care questionnaire according to classical and item response theory analyses.
    Panouillères M; Anota A; Nguyen TV; Brédart A; Bosset JF; Monnier A; Mercier M; Hardouin JB
    Qual Life Res; 2014 Sep; 23(7):2089-101. PubMed ID: 24604076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Rasch analysis of the Person-Centred Climate Questionnaire - staff version.
    Wilberforce M; Sköldunger A; Edvardsson D
    BMC Health Serv Res; 2019 Dec; 19(1):996. PubMed ID: 31878914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychometric evaluation of an interview-administered version of the Kessler 10-item questionnaire (K10) for measuring psychological distress in rural Bangladesh.
    Uddin MN; Islam FMA; Al Mahmud A
    BMJ Open; 2018 Jun; 8(6):e022967. PubMed ID: 29961041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rasch model of the bridging social capital questionnaire.
    Villalonga-Olives E; Kawachi I; Rodríguez AM
    SSM Popul Health; 2021 Jun; 14():100791. PubMed ID: 33997242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement properties of the 12-item Short Form Health Survey version 2 in Australians with lung cancer: a Rasch analysis.
    Soh SE; Morello R; Ayton D; Ahern S; Scarborough R; Zammit C; Brand M; Stirling RG; Zalcberg J
    Health Qual Life Outcomes; 2021 May; 19(1):157. PubMed ID: 34059079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Patient Activation Measure-13 (PAM-13) in an oncology patient population: psychometric properties and dimensionality evaluation.
    Roesel I; Froehlich D; Joos S; Valentini J; Mauch H; Martus P
    Health Qual Life Outcomes; 2024 May; 22(1):39. PubMed ID: 38764032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development, Internal Construct, and Unidimensionality of the Tetraplegia Upper Limb Activities Questionnaire, TUAQ. Part 1.
    Wangdell J; Hill B; Dunn JA
    Arch Phys Med Rehabil; 2022 Nov; 103(11):2189-2196. PubMed ID: 35595068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring physical and mental health during pregnancy and postpartum in an Australian childbearing population - validation of the PROMIS Global Short Form.
    Slavin V; Gamble J; Creedy DK; Fenwick J; Pallant J
    BMC Pregnancy Childbirth; 2019 Oct; 19(1):370. PubMed ID: 31640626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and evaluation of the Norwegian Fatigue Characteristics and Interference Measure (FCIM) for stroke survivors: cognitive interviews and Rasch analysis.
    Skogestad IJ; Kottorp A; Larsson P; Moen TM; Gay CL; Borge CR; Lerdal A
    Qual Life Res; 2023 Dec; 32(12):3389-3401. PubMed ID: 37468806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A psychometric evaluation of the Ethical Leadership Scale using Rasch analysis and confirmatory factor analysis.
    Sen S; Gocen A
    J Gen Psychol; 2021; 148(1):84-104. PubMed ID: 33100174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construct validity of the anglicised FACE-Q skin cancer module.
    Dobbs TD; Harrison CJ; Ottenhof MJ; Gibson JAG; Matin RN; Rodrigues JN; Hutchings HA; Whitaker IS
    J Plast Reconstr Aesthet Surg; 2022 May; 75(5):1644-1652. PubMed ID: 34955401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating the quality of life impact of recurrent urinary tract infection: Validation and refinement of the Recurrent UTI Impact Questionnaire (RUTIIQ).
    Newlands AF; Kramer M; Roberts L; Maxwell K; Price JL; Finlay KA
    Neurourol Urodyn; 2024 Apr; 43(4):902-914. PubMed ID: 38385648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sexual Morbidity Assessment in Gyne-Oncology Follow-Up: Development of the Sexual Well-Being After Cervical or Endometrial Cancer (SWELL-CE) Patient-Reported Outcome Measure.
    White ID; Tennant A; Taylor C
    J Sex Med; 2020 Oct; 17(10):2005-2015. PubMed ID: 32741745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.